2023 annual financial data
Senti Biosciences Holdings 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -2,648.89%.
Operating income was -92,727,000 USD and net income was -71,058,000 USD.
Operating cash flow was -52,395,000 USD.
Get free Senti Biosciences Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,978,000 USD
- Operating income
- -92,727,000 USD
- Net income
- -71,058,000 USD
- Operating cash flow
- -52,395,000 USD